PubMed for id: 439181

Year	Number of Results
1995	1
1996	2
2001	2
2003	1
2004	1
2006	3
2007	3
2008	2
2009	4
2010	1
2011	4
2012	1
2016	2
2017	1
2024	0

1

Loss of DLG5 promotes breast cancer malignancy by inhibiting the Hippo signaling pathway.

Liu J, Li J, Li P, Wang Y, Liang Z, Jiang Y, Li J, Feng C, Wang R, Chen H, Zhou C, Zhang J, Yang J, Liu P. Liu J, et al. Sci Rep. 2017 Feb 7;7:42125. doi: 10.1038/srep42125. Sci Rep. 2017. PMID: 28169360 Free PMC article.

2

DLG5 connects cell polarity and Hippo signaling protein networks by linking PAR-1 with MST1/2.

Kwan J, Sczaniecka A, Heidary Arash E, Nguyen L, Chen CC, Ratkovic S, Klezovitch O, Attisano L, McNeill H, Emili A, Vasioukhin V. Kwan J, et al. Genes Dev. 2016 Dec 15;30(24):2696-2709. doi: 10.1101/gad.284539.116. Genes Dev. 2016. PMID: 28087714 Free PMC article.

3

Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120.

Yuan Z, Kim D, Shu S, Wu J, Guo J, Xiao L, Kaneko S, Coppola D, Cheng JQ. Yuan Z, et al. J Biol Chem. 2016 Oct 21;291(43):22858. doi: 10.1074/jbc.A109.059675. J Biol Chem. 2016. PMID: 27825096 Free PMC article. No abstract available.

4

The phenotype of human STK4 deficiency.

Abdollahpour H, Appaswamy G, Kotlarz D, Diestelhorst J, Beier R, Schäffer AA, Gertz EM, Schambach A, Kreipe HH, Pfeifer D, Engelhardt KR, Rezaei N, Grimbacher B, Lohrmann S, Sherkat R, Klein C. Abdollahpour H, et al. Blood. 2012 Apr 12;119(15):3450-7. doi: 10.1182/blood-2011-09-378158. Epub 2012 Jan 31. Blood. 2012. PMID: 22294732 Free PMC article.

5

MST1 is a multifunctional caspase-independent inhibitor of androgenic signaling.

Cinar B, Collak FK, Lopez D, Akgul S, Mukhopadhyay NK, Kilicarslan M, Gioeli DG, Freeman MR. Cinar B, et al. Cancer Res. 2011 Jun 15;71(12):4303-13. doi: 10.1158/0008-5472.CAN-10-4532. Epub 2011 Apr 21. Cancer Res. 2011. PMID: 21512132 Free PMC article.

6

Hippo/Mst1 stimulates transcription of the proapoptotic mediator NOXA in a FoxO1-dependent manner.

Valis K, Prochazka L, Boura E, Chladova J, Obsil T, Rohlena J, Truksa J, Dong LF, Ralph SJ, Neuzil J. Valis K, et al. Cancer Res. 2011 Feb 1;71(3):946-54. doi: 10.1158/0008-5472.CAN-10-2203. Epub 2011 Jan 18. Cancer Res. 2011. PMID: 21245099

7

MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation.

Yuan F, Xie Q, Wu J, Bai Y, Mao B, Dong Y, Bi W, Ji G, Tao W, Wang Y, Yuan Z. Yuan F, et al. J Biol Chem. 2011 Mar 4;286(9):6940-5. doi: 10.1074/jbc.M110.182543. Epub 2011 Jan 6. J Biol Chem. 2011. PMID: 21212262 Free PMC article.

8

The tumor suppressor RASSF1A prevents dephosphorylation of the mammalian STE20-like kinases MST1 and MST2.

Guo C, Zhang X, Pfeifer GP. Guo C, et al. J Biol Chem. 2011 Feb 25;286(8):6253-61. doi: 10.1074/jbc.M110.178210. Epub 2011 Jan 3. J Biol Chem. 2011. PMID: 21199877 Free PMC article.

9

Phosphoinositide 3-kinase/Akt inhibits MST1-mediated pro-apoptotic signaling through phosphorylation of threonine 120.

Yuan Z, Kim D, Shu S, Wu J, Guo J, Xiao L, Kaneko S, Coppola D, Cheng JQ. Yuan Z, et al. J Biol Chem. 2010 Feb 5;285(6):3815-3824. doi: 10.1074/jbc.M109.059675. Epub 2009 Nov 24. J Biol Chem. 2010. PMID: 19940129 Free PMC article. Retracted.

10

RASSF2 associates with and stabilizes the proapoptotic kinase MST2.

Cooper WN, Hesson LB, Matallanas D, Dallol A, von Kriegsheim A, Ward R, Kolch W, Latif F. Cooper WN, et al. Oncogene. 2009 Aug 20;28(33):2988-98. doi: 10.1038/onc.2009.152. Epub 2009 Jun 15. Oncogene. 2009. PMID: 19525978 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

27 results

Results by year